Identification

Instrument name
ELI LILLY AND COMPANY
Symbol
LLY
ISIN code
US5324571083
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
ICB
Pharmaceuticals
Activity description

Eli Lilly and Company is one of the world’s leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

  • neurology (33.5%): primarily drugs used in treating depression and schizophrenia;
  • endocrinology (30.1%): products for treating osteoporosis, diabetes, and growth problems;
  • oncology (14.5%);
  • cardiovascular diseases (11.7%);
  • veterinary medicine (9%);
  • other (1.2%).

Net sales are distributed geographically as follows: the United States (54.5%), Europe (18.9%), Japan (9.9%) and other (16.7%).
Source: Cofisem

Website address
http://www.lilly.com

Operation

IPO date
Mon 25/03/2013
IPO type

Direct listing

Catégorie
IPO